SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-046319
Filing Date
2023-12-28
Accepted
2023-12-28 06:02:59
Documents
13
Period of Report
2023-12-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 61263
  Complete submission text file 0001493152-23-046319.txt   283861

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cing-20231226.xsd EX-101.SCH 3781
3 XBRL DEFINITION FILE cing-20231226_def.xml EX-101.DEF 26635
4 XBRL LABEL FILE cing-20231226_lab.xml EX-101.LAB 36734
5 XBRL PRESENTATION FILE cing-20231226_pre.xml EX-101.PRE 25259
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5226
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 231519271
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)